107323-82-0

Basic information

• Product Name: Magnesium, bromo[(4-chlorophenyl)methyl]-
• Synonyms: .p-Chlor-benzylmagnesiumbromid;.4-Chlor-benzylmagnesium-bromid;p-chlorobenzylmagnesium bromide
• CAS NO: 107323-82-0
• Molecular Formula: C7H6BrClMg
• Molecular Weight: 229.787
• Mol File: 107323-82-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Magnesium, bromo[(4-chlorophenyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Magnesium, bromo[(4-chlorophenyl)methyl]-(107323-82-0)
• EPA Substance Registry System: Magnesium, bromo[(4-chlorophenyl)methyl]-(107323-82-0)

Safety Data

• Hazardous Substances Data: 107323-82-0(Hazardous Substances Data)

Upstream product

• 622-95-7 4-chlorobenzyl bromide 

Downstream Products

• 7504-29-2 1-(2-chlorophenyl)-2-(4-chlorophenyl)ethanone 
• 5468-97-3 1-(4-chlorophenyl)-2-methyl-2-propanol 
• 51490-05-2 1,2-bis(4-chlorophenyl)ethanone 
• 3047-24-3 4-(p-chlorophenyl)-1-butene 
• 100199-04-0 (1S,2S)-1-(4-Chloro-benzyl)-2-[1,2,4]triazol-1-yl-cyclohexanol 
• 100199-04-0 (1S,2R)-1-(4-Chloro-benzyl)-2-[1,2,4]triazol-1-yl-cyclohexanol 
• 39489-86-6 3,3-dimethyl-1-(4-chlorophenyl)butan-2-one 
• 53541-89-2 3-(4-chlorobenzyl)-1H-indole 
• 1359816-25-3 4-(4-chlorobenzyl)-2-dimethyl-amino-5-(4-isopropoxyphenylamino)pyrimidine 

Relevant articles and documents

Dynamic kinetic asymmetric cross-benzoin additions of β-stereogenic α-keto esters

The dynamic kinetic resolution of β-halo α-keto esters via an asymmetric cross-benzoin reaction is described. A chiral N-heterocyclic carbene catalyzes the umpolung addition of aldehydes to racemic α-keto esters. The resulting fully substituted β-halo glycolic ester products are obtained with high levels of enantio- and diastereocontrol. The high chemoselectivity observed is a result of greater electrophilicity of the α-keto ester toward the Breslow intermediate. The reaction products are shown to undergo highly diastereoselective substrate-controlled reduction to give highly functionalized stereotriads.

NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun